Naproxen Mylan

Naproxen, the active ingredient in Naproxen Mylan, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is used to relieve pain, reduce inflammation, and lower fever in adults. GNH USA supplies Naproxen Mylan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts on inflammatory pathways to provide analgesic and anti‑inflammatory benefits across several conditions.

Pain relief: Provides effective analgesia for mild to moderate acute pain. Inflammation reduction: Decreases swelling and inflammation in musculoskeletal disorders. Fever reduction: Lowers elevated body temperature associated with febrile illnesses. Osteoarthritis: Improves joint function and reduces discomfort in degenerative joint disease. Rheumatoid arthritis: Helps control pain and inflammation in autoimmune joint disease.

Naproxen may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia) - Headache - Dizziness - Abdominal pain - Diarrhoea - Rash or mild skin irritation

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Cardiovascular events such as myocardial infarction - Renal impairment or failure - Severe skin reactions (Stevens‑Johnson syndrome) - Hepatic dysfunction - Anaphylaxis or severe allergic reactions

Before using Naproxen, consider the following safety measures.

Assess gastrointestinal risk: Evaluate history of ulcers or bleeding. Monitor renal function: Check kidney health, especially in older patients. Avoid in known hypersensitivity: Do not use if allergic to NSAIDs. Use caution with cardiovascular disease: Weigh benefits against thrombotic risk. Avoid concomitant use with other NSAIDs or aspirin: Increases bleeding risk. Store at room temperature: Keep in the original pack, protect from moisture.

Naproxen can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - Lithium: elevated lithium serum concentrations. - Methotrexate: reduced clearance leading to toxicity. - ACE inhibitors: possible renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal function. - Beta‑blockers: potential reduction in antihypertensive effect. - Corticosteroids: increased risk of ulcer formation.